by S. Nass, H. Moses
Publisher: National Academies Press 2007
Number of pages: 252
Many cancer patients are diagnosed at a stage in which the cancer is too far advanced to be cured, and most cancer treatments are effective in only a minority of patients undergoing therapy. Thus, there is tremendous opportunity to improve the outcome for people with cancer by enhancing detection and treatment approaches. Biomarkers will be instrumental in making that transition.
Home page url
Download or read it online for free here:
by Matthias Rath - M/R Pub
This book provides a summary of the progress of Cellular Health in the battle against several forms of cancer and infectious diseases, as well as other serious diseases. It substantiates the fact that cancer will lose its threat.
by Paul Eggleton, et al. - Frontiers Media SA
The endoplasmic reticulum (ER) is an organelle crucial to many cellular functions and processes. ER has a well-established central role in anti-tumor immunity. Perhaps best characterized is the role of the ER in the processing of antigen peptides.
- Royal College of General Practitioners
The guideline covers twelve groups of cancers: lung, upper gastrointestinal cancers, lower gastrointestinal cancers, breast cancer, gynaecological cancers, urological cancers, haematological cancers, skin cancers, head and neck cancers, etc.
- National Institute for Health and Care Excellence
This guideline aims to facilitate standardisation of practice in treating non-Hodgkin's lymphoma. But because of the rapid development of new therapies as a result of improved understanding of the disease, continual re-evaluation will be essential.